BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 17558857)

  • 1. The role of epithelial-mesenchymal transition in cancer pathology.
    Guarino M; Rubino B; Ballabio G
    Pathology; 2007 Jun; 39(3):305-18. PubMed ID: 17558857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition and tumour invasion.
    Guarino M
    Int J Biochem Cell Biol; 2007; 39(12):2153-60. PubMed ID: 17825600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; Rosanò L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells.
    Cannito S; Novo E; Compagnone A; Valfrè di Bonzo L; Busletta C; Zamara E; Paternostro C; Povero D; Bandino A; Bozzo F; Cravanzola C; Bravoco V; Colombatto S; Parola M
    Carcinogenesis; 2008 Dec; 29(12):2267-78. PubMed ID: 18791199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas.
    Wells A; Yates C; Shepard CR
    Clin Exp Metastasis; 2008; 25(6):621-8. PubMed ID: 18600305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells.
    Theys J; Jutten B; Habets R; Paesmans K; Groot AJ; Lambin P; Wouters BG; Lammering G; Vooijs M
    Radiother Oncol; 2011 Jun; 99(3):392-397. PubMed ID: 21680037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.
    Ding W; You H; Dang H; LeBlanc F; Galicia V; Lu SC; Stiles B; Rountree CB
    Hepatology; 2010 Sep; 52(3):945-53. PubMed ID: 20564331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
    McCart Reed AE; Kutasovic JR; Vargas AC; Jayanthan J; Al-Murrani A; Reid LE; Chambers R; Da Silva L; Melville L; Evans E; Porter A; Papadimos D; Thompson EW; Lakhani SR; Simpson PT
    J Pathol; 2016 Mar; 238(4):489-94. PubMed ID: 26510554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial mesenchymal transition during the neoplastic transformation of human breast epithelial cells by estrogen.
    Tiezzi DG; Fernandez SV; Russo J
    Int J Oncol; 2007 Oct; 31(4):823-7. PubMed ID: 17786313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
    Giannelli G; Bergamini C; Fransvea E; Sgarra C; Antonaci S
    Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression.
    Moustakas A; Heldin CH
    Cancer Sci; 2007 Oct; 98(10):1512-20. PubMed ID: 17645776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition in development and cancer.
    Micalizzi DS; Ford HL
    Future Oncol; 2009 Oct; 5(8):1129-43. PubMed ID: 19852726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition in cancer development and its clinical significance.
    Iwatsuki M; Mimori K; Yokobori T; Ishi H; Beppu T; Nakamori S; Baba H; Mori M
    Cancer Sci; 2010 Feb; 101(2):293-9. PubMed ID: 19961486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.
    Larue L; Bellacosa A
    Oncogene; 2005 Nov; 24(50):7443-54. PubMed ID: 16288291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells.
    Topel H; Bagirsakci E; Comez D; Bagci G; Cakan-Akdogan G; Atabey N
    Cell Commun Signal; 2020 Jul; 18(1):110. PubMed ID: 32650779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epithelial-mesenchymal transitions in cancer onset and progression].
    Thiery JP
    Bull Acad Natl Med; 2009 Dec; 193(9):1969-78; discussion 1978-9. PubMed ID: 20666011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion.
    Gardberg M; Kaipio K; Lehtinen L; Mikkonen P; Heuser VD; Talvinen K; Iljin K; Kampf C; Uhlen M; Grénman R; Koivisto M; Carpén O
    PLoS One; 2013; 8(9):e74923. PubMed ID: 24086398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract.
    Natalwala A; Spychal R; Tselepis C
    World J Gastroenterol; 2008 Jun; 14(24):3792-7. PubMed ID: 18609701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.